(12) Patent Application Publication (10) Pub. No.: US 2016/0166687 A1 Schultz Et Al

(12) Patent Application Publication (10) Pub. No.: US 2016/0166687 A1 Schultz Et Al

US 2016O166687A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0166687 A1 Schultz et al. (43) Pub. Date: Jun. 16, 2016 (54) DIRECTED DIFFERENTATION OF Publication Classification OLGODENIDROCYTE PRECURSORCELLS TO A MYELINATING CELL FATE (51) Int. Cl. A 6LX39/395 (2006.01) (71) Applicants: The Scripps Research Institute, La A613 L/35 (2006.01) Jolla, CA (US); IRM LLC, Hamilton A638/2I (2006.01) (BM) A63/545 (2006.01) A63/37 (2006.01) (72) Inventors: Peter Schultz, La Jolla, CA (US); Luke A613 L/439 (2006.01) Lairson, San Diego, CA (US); Vishal A613 L/40 (2006.01) Deshmukh, La Jolla, CA (US); Costas (52) U.S. Cl. Lyssiotis, Boston, MA (US) CPC ........... A61K.39/3955 (2013.01); A61K3I/439 (2013.01); A61 K3I/135 (2013.01); A61 K 31/40 (2013.01); A61 K31/5415 (2013.01); (21) Appl. No.: 14/973,105 A6 IK3I/137 (2013.01); A61 K38/215 (2013.01) (22) Filed: Dec. 17, 2015 (57) ABSTRACT The present invention provides methods of inducing differ entiation of oligodendrocyte progenitor cells to a mature Related U.S. Application Data myelinating cell fate with a neurotransmitter receptor modu lating agent. The present invention also provides methods of (62) Division of application No. 13/985,342, filed on Oct. stimulating increased myelination in a Subject in need thereof 18, 2013, filed as application No. PCT/US2012/ by administering said neurotransmitter receptor modulating 025712 on Feb. 17, 2012. agent. Methods of treating a subject having a demyelinating (60) Provisional application No. 61/444,666, filed on Feb. disease using a neurotransmitter receptor modulating agent 18, 2011. are also provided. Patent Application Publication Jun. 16, 2016 Sheet 1 of 52 US 2016/O166687 A1 Fig. A A. y as ---o---&e - ...? - (C. 1- os-s s is - -w N les d ser:Sties ECsxf3 : - Y - - AN ls-N- s-S s f t lass-s-CJC-s--as-SE a^----->-9s-s-s- Y- asso; st - S. Saietara Esox e ass-Ya-Y^N S3? SS- Ys- s^\ or say 33S: Csex 88) s Patent Application Publication Jun. 16, 2016 Sheet 2 of 52 US 2016/O166687 A1 Fig. 1 B-C B. sexes eastific - GBR 12935 rte Trifuroperazine -- Carbetapentane/ 3 or Benztropirie A £3. 328i a & S. o compound ut C. 83 x. Pot&scy : 8. Patent Application Publication Jun. 16, 2016 Sheet 3 of 52 US 2016/O166687 A1 Fig. 2A VS 3 3: Benzatropine 4: Carbapentarie 5: Clemastine s: BR3s : Sarreteroi Patent Application Publication Jun. 16, 2016 Sheet 4 of 52 US 2016/O166687 A1 Fig. 2B-C MBP or PCR fs aaaaaaassassessex sessssssssssex MOG qrTPCR ' Patent Application Publication Jun. 16, 2016 Sheet 5 of 52 US 2016/O166687 A1 Fig. 3 S. Eenza tropiirig Certasting Carbagentaris rifoperazine Sainstger 3. s Patent Application Publication Jun. 16, 2016 Sheet 6 of 52 US 2016/O166687 A1 Patent Application Publication Jun. 16, 2016 Sheet 7 of 52 US 2016/O166687 A1 Fig. 5A Mycophenoiate S: view 8::::8 2. l rurvyce::::::::giate 2. s m 3. c X s : 8 : - X - ; ; ; ; i. 8,s : Y e 8: M 8 is is a 3 is is 8:232; asks: 33 days Patent Application Publication Jun. 16, 2016 Sheet 8 of 52 US 2016/O166687 A1 Fig. 5B-C , Berizatropine 3. are feice 3: --8es:stropis: 3. 8S. B.S 38 8 : 2: 3 x 3 8 8 3 & 1 : 3 x 38 88233:32:32:3S28.238883 bays Berizatropine + Mycophenotate C. $8. view Veiicie 83 w- 88:a::pin83-8:ysogies: is 2.8 raw -- s s & : & f is: e ar -- a s 8 see 8. s 3 s : 8 8 & St: 31:383 & 832 &23 &2S288883 says Patent Application Publication Jun. 16, 2016 Sheet 9 of 52 US 2016/O166687 A1 Fig. 5D-E , rifluoperazine 3.8 were fe:::::::: waii:iog&razi& 3. S. : S. - i. 88. 3 : R 3 & 8 & 8 3 - 3 3 SS 8 SR32 &33.823 & 288383 ays E. rifitioperazine + Mycopheridiate 38 area ixticia 28 re-fiftgesperagine-8-ycopiesotate 3. 8 s sk t & 8S 88: 3 a 3 & 8 & 2 8 & St 323 & 33 8: 8832 & 23 23828 2:28:28 383; says Patent Application Publication Jun. 16, 2016 Sheet 10 of 52 US 2016/0166687 A1 Fig. 6A-B A. w8 20- ox & g15... xx x CabapentaréAX. e- x- Beizatioisie | glo- wer Safete:{: N. x - o Conc. (ab3880i is 3. also Sametro, GBR12935, , , , Trifluoperazine, 3. Benztropine, Carbapentane, Ciennastine Patent Application Publication Jun. 16, 2016 Sheet 11 of 52 US 2016/O166687 A1 Fig. 7-i-C A. Berztragine is is: 88:tragie C. Cartacitoi (3:38 Cart:8::it: ,8. i carbacio; 4,7uki is soil 88xtropise 3.3ai) Patent Application Publication Jun. 16, 2016 Sheet 12 of 52 US 2016/O166687 A1 Fig. 8A-B A. case feise .x. Benxtropine herapeutic * Bextropine Prophylactic : -- FTY720 Therapeutic -x.interferon- herapeutic 3. s 2ogo. Ovehicle s: Bextrepine p-905 tooo soo x S Patent Application Publication Jun. 16, 2016 Sheet 13 of 52 US 2016/O166687 A1 Fig. 8C Patent Application Publication Jun. 16, 2016 Sheet 14 of 52 US 2016/O166687 A1 Ciprixote ost Ciprixote iftistiawa :::::K 88k 8& 3 &:::::: co grey sess co-st vehisie &extrepite seates Patent Application Publication Jun. 16, 2016 Sheet 15 of 52 US 2016/O166687 A1 Fig. (A-B A. : see fei: - 8 FY720 mg/kg 4.0 * BA 2.5mg/kg : "*" FTY720 irrigkg - : 3.5 8A 2.5 kg & 3.0 8 2.5- a 2.8 s s: : 3. 0.0 ex-rm: ''''''''''''''''''' -----------------------... s : s 3ys fee .x. F8-3 (0. -x Bk 3.3 gig -x-x- E - 882.sg/kg w - X: s ' x Yw- .xx 8:8 - 8& o, obsessm--------------------------------- s · s 3. 3y & Patent Application Publication Jun. 16, 2016 Sheet 16 of 52 US 2016/O166687 A1 Fig. 10C-D easo fee wx FY720 O. mg/kg -- FTY720 mgkg * BA 2.5gkg 8-8-8-8-8-8-8-8-8-- --------------------------------------------------------------------, s 's x 3. ays 8. : ex feixie x FN-3 300 -x FN-3 (i. * 8A2. Singkg .5 0.0 esses ormer : s s : 3. k says Patent Application Publication Jun. 16, 2016 Sheet 17 of 52 US 2016/O166687 A1 Fig. 10E-F mix fecies 4.0. « FY720 mg/kg x Y23 ... gkg 883.Stigkg o,0s sex5 circrto is 20 as 3e says F. xx feiseik x F-8 (388 x F8-380 s 8 - 8x----------------------------------------- ------------------- ---. s s 28 3: 3ys Patent Application Publication Jun. 16, 2016 Sheet 18 of 52 US 2016/O166687 A1 Fig. 1 (A-B 3883: ar. ^ Styxxic hier888 8x & Oligocencirocyte Patent Application Publication Jun. 16, 2016 Sheet 19 of 52 US 2016/O166687 A1 Fig. 2A-B are 88tatropite Ecse 358 & 8. 8.33: 383 . Conc. (i. 88::::::::::::8 8.3: 8883xxxxxx 8.8 ::::: :yrexies sixx xxx: { Patent Application Publication Jun. 16, 2016 Sheet 20 of 52 US 2016/O166687 A1 Fig. 3 B Atti Patent Application Publication Jun. 16, 2016 Sheet 21 of 52 US 2016/O166687 A1 Fig. 14 tyroix: 3883 88:::::::: x38x3:38 Patent Application Publication Jun. 16, 2016 Sheet 22 of 52 US 2016/O166687 A1 Patent Application Publication Jun. 16, 2016 Sheet 23 of 52 US 2016/O166687 A1 A. Benztropied hyroid erroref OCS SO S. T. Apod T-s""or "".2" Enpp6 .a. 11.58; S.06 -----------------Mag. 0.10.3.70...4.64. Mbp .5 --> 3.88 3.55 ... Mobp . .0.46 2.04 87.70 . .wog. ... 0.2 ... .88.i.28.23. Oig .98 O.97 O.75 Pip G.17 97 2.33 Prip 1. 0.44 3.3a 3. Tpd52 24 2.28 2. S (CfS Berztropinei hyroid Hormonel S S. Patent Application Publication Jun. 16, 2016 Sheet 24 of 52 US 2016/O166687 A1 Fig. 7A-B A. Day 6 lay ::::::::::::: & Day 1 ::::::::::::: & say 3 d :::::::::::: lay d 8:33:38& 8:3 say $. *:::::iy 88.8 xx IBEY., od ORY.S. on Patent Application Publication Jun. 16, 2016 Sheet 25 of 52 US 2016/O166687 A1 Fig. 17C-D Berztropire .5 Mt Day 0 ay Day 2 Day 3 lay 4 lay 5 i Betztropire .5u Day 3 ay 4 ay 5 Day 8 Patent Application Publication Jun. 16, 2016 Sheet 26 of 52 US 2016/O166687 A1 Fig. 18 S. Casaki is...} Bextropire (2.3a;-- $3.338 &S Patent Application Publication Jun. 16, 2016 Sheet 27 of 52 US 2016/O166687 A1 Fig. 194-B A. 8. 8 36 w x 8. s: 2 Betztropite (.8 it Histamine ii.7 uti) is&ies .38: Histantire (3 tit} B. i Benetrapine it.8 til Rif (s.7 as: 8, 8. hit 8 (0 tit} Patent Application Publication Jun. 16, 2016 Sheet 28 of 52 US 2016/O166687 A1 Fig. 204-B s i Benztropine it.8 it Quiripiroie (4.7 at tipirote (0.8 .it Quinpiroie to it i s Benztropine (.8 it taiaperidad (4.7 aii iaixperide: {{.{ ai: Hairsperidol (g at Patent Application Publication Jun. 16, 2016 Sheet 29 of 52 US 2016/O166687 A1 Fig. 21 -- oxyxyri - EC 8.8 six x &t epise i-Ecs: s. 38 x igratropi: i-Ecs: S.8 s. w topiyerine {-EC, 8.83 :: Sc{{{xiasise {^E{s: 3. 38: o, o os ooo cote. & Recepte Rii Recepto: i3 Reeete: Patent Application Publication Jun. 16, 2016 Sheet 30 of 52 US 2016/O166687 A1 Fig. 23A A. *:::::::ces : s ::: 33 8. *:::ssion p38xtapK esta p38 is: ph:3spher &ist faste: 8xt 88sho 32f& xiàK exai 83 f$8 wArK. Piaspx E8 issi E3 Patent Application Publication Jun.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    99 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us